PerkinElmer Board Declares Quarterly Dividend
The Board of Directors of PerkinElmer, Inc. , declared a regular quarterly dividend of $0.07 per share of common stock on July 24, 2014.
PerkinElmer Coverage Initiated at Citigroup Inc.
The firm set a "buy" rating and a $55.00 price target on the stock. Citigroup Inc.'s target price suggests a potential upside of 19.31% from the company's current price.
PerkinElmer to Hold Earnings Call on Thursday, July 31, 2014
The Company will also host a conference call the same day at 5:00 p.m. ET to discuss these results.
PerkinElmer Price Target Increased to $53.00 by Analysts at Cowen and Company
Cowen and Company's target price would indicate a potential upside of 11.32% from the company's previous close.
Enzo Biochem Announces Settlement Agreement with PerkinElmer
Enzo Biochem, Inc. , along with its subsidiary Enzo Life Sciences, Inc. entered into a Settlement with PerkinElmer, Inc. and PerkinElmer Health Sciences, Inc. with respect to an action between the Company and PerkinElmer before the U.S. District Court, Southern District of New York, Case No 03-CV-3817.